Cachexia is a syndrome of unintentional body weight loss and muscle wasting occurring in
30% of all cancer patients. Patients with cancers most commonly leading to brain …

The aim of this study was to assess the available evidence regarding the effect of a variety of
fasting-like regimens on preventing chemotherapy-related side effects. PubMed, Scopus …

Background Inflammation and nutrition and depression are interrelated, and both are related
to changes in mortality rates. We investigated the association of nutritional and inflammation …

The complex interplay between nutrition and inflammation has become a major focus of
research in recent years across different clinical settings and patient populations …

Cachexia is characterized by severe weight loss and skeletal muscle depletion, and is a
threat to cancer patients by worsening their prognosis. International guidelines set …

Importance In the era of immuno-oncology, imaging alone seems to be insufficient to capture
treatment responses, as patients with stable disease treated with immunotherapy have a …

The development of cachexia in the setting of cancer or other chronic diseases is a
significant detriment for patients. Cachexia is associated with a decreased ability to tolerate …

Background and Objectives: The prevalence of cachexia has increased across all of the
cancer types and accounts for up to 20% of cancer-related deaths. This paper is a …

Background The effects of some drugs, aging, cancers, and other diseases can cause
muscle wasting. Currently, there are no effective drugs for treating muscle wasting. In this …

Cancer-associated cachexia (CAC) is a critical contributor to pancreatic ductal
adenocarcinoma (PDAC) mortality. Thus, there is an urgent need for new strategies to …